This company combines impressive quality with a generous valuation: AnaptysBio Inc. (ANAB)

In the latest session, AnaptysBio Inc. (NASDAQ: ANAB) closed at $25.17 up 0.16% from its previous closing price of $25.13. In other words, the price has increased by $+0.04 from its previous closing price. On the day, 1515017 shares were traded. ANAB stock price reached its highest trading level at $25.44 during the session, while it also had its lowest trading level at $24.60.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

Ratios:

For a deeper understanding of AnaptysBio Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.40 and its Current Ratio is at 21.40. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

On November 01, 2022, Guggenheim Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $44.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 08 when LOUMEAU ERIC J sold 2,500 shares for $24.00 per share. The transaction valued at 60,000 led to the insider holds 523 shares of the business.

LOUMEAU ERIC J sold 1,146 shares of ANAB for $23,493 on May 18. The COO, General Counsel now owns 523 shares after completing the transaction at $20.50 per share. On May 05, another insider, EcoR1 Capital, LLC, who serves as the 10% Owner of the company, bought 668,237 shares for $21.63 each. As a result, the insider paid 14,453,966 and bolstered with 7,521,024 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 155.22 while its Price-to-Book (P/B) ratio in mrq is 2.57.

Stock Price History:

Over the past 52 weeks, ANAB has reached a high of $34.33, while it has fallen to a 52-week low of $18.20. The 50-Day Moving Average of the stock is 27.66, while the 200-Day Moving Average is calculated to be 24.64.

Shares Statistics:

For the past three months, ANAB has traded an average of 252.04K shares per day and 342.87k over the past ten days. A total of 28.43M shares are outstanding, with a floating share count of 28.34M. Shares short for ANAB as of Oct 13, 2022 were 5.49M with a Short Ratio of 5.38M, compared to 5.41M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 19.45% and a Short% of Float of 27.83%.

Earnings Estimates

There are 6 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.76 for the current quarter, with a high estimate of $0.82 and a low estimate of -$1.18, while EPS last year was -$0.24. The consensus estimate for the next quarter is -$1, with high estimates of -$0.63 and low estimates of -$1.2.

Analysts are recommending an EPS of between -$2.06 and -$4.93 for the fiscal current year, implying an average EPS of -$4.05. EPS for the following year is -$3.7, with 7 analysts recommending between $0.07 and -$5.41.

Revenue Estimates

A total of 7 analysts believe the company’s revenue will be $10.34M this quarter.It ranges from a high estimate of $48.64M to a low estimate of $1.2M. As of the current estimate, AnaptysBio Inc.’s year-ago sales were $20.89M, an estimated decrease of -50.50% from the year-ago figure. For the next quarter, 7 analysts are estimating revenue of $5.31M, an increase of 425.20% over than the figure of -$50.50% in the same quarter last year. There is a high estimate of $19M for the next quarter, whereas the lowest estimate is $620k.

A total of 7 analysts have provided revenue estimates for ANAB’s current fiscal year. The highest revenue estimate was $55.89M, while the lowest revenue estimate was $4.7M, resulting in an average revenue estimate of $18.46M. In the same quarter a year ago, actual revenue was $63.17M, down -70.80% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $25.07M in the next fiscal year. The high estimate is $60.02M and the low estimate is $5.2M. The average revenue growth estimate for next year is up 35.80% from the average revenue estimate for this year.